All Valley locations are open, safe and ready to care for you. Call 1-800-VALLEY 1 (1-800-825-5391) to schedule a Safe Visit with a Valley Medical Group provider.Read More
MD, Temple University School Of Medicine, 1977 - 1981
BA, Univ Of Rochester School Of Medicine, 1974 - 1977
Long Island Jewish-Hillside Medical Center, Cardiology, 1984 - 1986
- Internship & Residency
Albany Medical Center, Internal Medicine, 1981 - 1984
- Board Certifications
American Board Of Internal Medicine - Certified, 1984
Subspecialty Board Of Cardiovascular Disease - Certified, 1987
Get to Know Me
What are some of the specific conditions you treat?
Coronary artery disease, myocardial infarction, atrial fibrillation, congestive heart failure, palpitations, hypertension, arrhythmias, pacemaker management, edema, aortic valve disease, mitral valve disease, mitral valve prolapse, aortic aneurysm, PAD-peripheral artery disease, lipid disorders, elevated cholesterol.
What techniques or procedures do you use in your practice?
We care for our patients with the latest techniques in cardiac diagnosis including noninvasive and invasive modalities.
Describe some of your professional highlights.
- Fellow of the American College of Cardiology.
- Board certified in internal medicine, cardiovascular diseases.
- Board certified in invasive cardiology.
Publications & Research
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome.
Cardiovascular Inflammation Reduction Trial (CIRT)
The Cardiovascular Inflammation Reduction Trial (CIRT) is a randomized clinical trial investigating whether taking low-dose methotrexate reduces heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome that have had a heart attack or multiple coronary blockages. This trial is funded by the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH).
Valley Medical Group providers accept the following plans.